Frovatriptan versus zolmitriptan for the acute treatment of migraine with aura: a subgroup analysis of a double-blind, randomized, multicenter, Italian study

Migraine with aura affects ~20–30 % of migraineurs and it is much less common than migraine without aura. The aim of this study was to compare the efficacy of frovatriptan 2.5 mg and zolmitriptan 2.5 mg in the treatment of migraine with aura. Analysis was carried out in a subset of 18 subjects with...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tullo, Vincenzo, Allais, Gianni, Curone, Marcella, Ferrari, Michel D., Omboni, Stefano, Benedetto, Chiara, Colombo, Bruno, Zava, Dario, Bussone, Gennaro
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Milan 2012
Témata:
Symposium: Open Questions on Migraine
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3362723/
https://ncbi.nlm.nih.gov/pubmed/22644173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10072-012-1043-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky